• Overview
  • Eligibility
  • More info
  • Locations

UWCCC Precision Medicine Molecular Tumor Board Registry (NCT03023202)

National Cancer Institute (NCI)
This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.
  • Other: PMMTB (Precision Medicine Molecular Tumor Board)
    PMMTB is a clinical intervention, NOT a research intervention. The research component of this study is to observe the outcomes of the PMMTB.
    Ages eligible for Study
    18 Years and older
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    No
    Inclusion Criteria:
    • Clinically suspected or histologically confirmed solid or hematological malignancy
    • Undergoing genetic testing of tumor
    • Ability to understand written informed consent document
    • Willingness to sign written informed consent document
    Exclusion Criteria:
    • Pediatric patients (age<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

    1 locations

    United States (1)
    • University of Wisconsin Carbone Cancer Center
      recruiting
      Madison, Wisconsin, United States, 53792
    Status:
    recruiting
    Type:
    Observational Patient Registry
    Phase:
    -
    Start:
    29 February, 2016
    Updated:
    12 January, 2017
    Participants:
    500
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!